Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

168.16
-0.6500-0.39%
Post-market: 167.61-0.5500-0.33%19:34 EDT
Volume:11.12M
Turnover:1.86B
Market Cap:43.39B
PE:-11.83
High:168.51
Open:168.23
Low:165.19
Close:168.81
52wk High:176.60
52wk Low:141.05
Shares:258.02M
Float Shares:258.02M
Volume Ratio:1.37
T/O Rate:4.31%
Dividend:2.55
Dividend Rate:1.52%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.26
PE(LYR):-11.83

Loading ...

JPMorgan Unfazed by Rising Rates Impact on China Healthcare, Remains Bullish on Biotech and CXO

Stock News
·
Oct 06

Trump: Thanks Howard Kessler for senior healthcare innovation

Trump's Truth Social latest posts
·
Oct 06

Thai Healthcare Sector Unlikely to be Impacted by Floods

Dow Jones
·
Oct 06

Tech Coast Angels Reports Profitable Atraverse Medical Exit After Johnson & Johnson Acquisition, Citing 70%+ IRR

Reuters
·
Oct 06

Patrys to Showcase Pipeline at MST Biotech & Healthcare Webinar

TIPRANKS
·
Oct 06

Macquarie Sticks to Its Buy Rating for Sigma Healthcare Ltd (S5YA)

TIPRANKS
·
Oct 06

L'Oreal Explores Unloading Chemical-Related Liabilities, WSJ Reports

Reuters
·
Oct 06

Molina Healthcare Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 06

Health Care up on Drug Breakthroughs

Dow Jones
·
Oct 06

Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call

GlobeNewswire
·
Oct 06

Promisia Welcomes Gould Holdings as Major Investor After Share and Warrant Selldown

TIPRANKS
·
Oct 06

Promisia Healthcare’s Brankin Family Trust Cuts Stake in $4.9m Share Sale to Gould Holdings

TIPRANKS
·
Oct 06

HCA Healthcare Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 06

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 06

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 06

AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense

Reuters
·
Oct 06

Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing

THOMSON REUTERS
·
Oct 06

Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing

THOMSON REUTERS
·
Oct 06

Abbvie Inc. Fy2026 Shr View $14.02

THOMSON REUTERS
·
Oct 06

Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing

THOMSON REUTERS
·
Oct 06